title: [Changing the paradigm: valsartan-inhibitor of neprilysin, a new dual-acting drug for arterial hypertension and heart failure].
authors.affiliation: Servicio de Cardiología, Hospital Vall d'Hebron, Barcelona, España. Electronic address: egalve@vhebron.net.
authors.forename: E
authors.initials: E
authors.lastname: Galve
authors.affiliation: Servicio de Cardiología, Hospital Vall d'Hebron, Barcelona, España.
authors.forename: G
authors.initials: G
authors.lastname: Casas-Masnou
authors.affiliation: Servicio de Cardiología, Hospital Vall d'Hebron, Barcelona, España.
authors.forename: D
authors.initials: D
authors.lastname: García-Dorado
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D015260:Neprilysin / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use; D014633:Valine / Q000627:therapeutic use; D000068756:Valsartan
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D013777:Tetrazoles; D000068756:Valsartan; D015260:Neprilysin; D014633:Valine